A clinical psychologist is studying the efficacy of a new drug medication for depression. The study includes a placebo group (no medication) versus a treatment group (new medication). He then measures the differences in depressive symptoms across the two groups.

What would a Type I error represent within the context of his study? How can he reduce the risk of committing a Type I error? How does this decision affect the risk of committing a Type II error?